1) Femoral nerve block
股神经阻滞
1.
Objective To study the analgetic effect of femoral nerve block on the patients with fresh femoral shaft fractures when they are being moved before operation and to solve the analgetic problem of preoperative patients of fractures in a safer and more effective way.
目的观察股神经阻滞对股骨干骨折患者术前搬动时的镇痛效果,为骨折患者术前提供更安全、有效的镇痛方法。
2) continuous femoral nerve block
连续股神经阻滞
1.
Objective To evaluate the analgetic and rehabilitative effect of epidural analgesia and continuous femoral nerve block after total knee replacement.
目的评估全膝关节置换术后硬膜外镇痛和连续股神经阻滞镇痛的效果及对患膝关节功能恢复的影响。
2.
OBJECTIVETo assess the influence of continuous femoral nerve block (CFNB) and IV patient-controlled analgesia (PCIA) on postoperative pain scores, knee rehabilitation and stress response after total knee arthroplasty (TKA).
目的评价连续股神经阻滞(Continuous Femoral Nerve Block,CFNB)能否降低全膝关节置换术(Total Knee Arthroplasty,TKA)病人的术后疼痛评分,提高病人对康复治疗的配合能力,减轻手术带来的应激反应。
3) femoral nerve block anesthesia
股神经阻滞麻醉
4) Continuous Femoral Nerve Block
连续性股神经阻滞
1.
Analgesia after Total Knee Arthroplasty: Continuous Femoral Nerve Block Versus Continuous Epidural Analgesia;
全膝置换术后连续性股神经阻滞镇痛和连续性硬膜外镇痛的效果比较
5) Nerve block
神经阻滞
1.
The comparison of intradermic injection and nerve block used for postherpetic neuralgia in aged patients;
皮内注射和神经阻滞疗法治疗老年带状疱疹后神经痛的比较
2.
The study on combination of nerve block with microwave medical for post-herpetic neuralgia;
神经阻滞联合微波治疗带状疱疹后遗神经痛的临床研究
6) phrenic nerve block
膈神经阻滞
1.
Clinical analysis of 32 cases with intractable hiccup who were treated with phrenic nerve block combined with haloperidol;
膈神经阻滞联合氟哌啶醇治疗顽固性呃逆32例临床分析
补充资料：抗肾上腺素能神经药、去甲肾上腺素能神经阻滞药
分子式：
CAS号：
性质：又称抗肾上腺素能神经药、去甲肾上腺素能神经阻滞药。指一类通过影响递质去甲肾上腺素在去甲肾上腺素能神经末梢的贮存，产生拮抗去甲肾上腺素能神经作用的药物。与抗肾上腺素药比较，二者作用相似但作用部位不同，抗肾上腺素药作用于效应器细胞的受体，而肾上腺素神经阻滞药作用于去甲肾上腺素能神经末梢。代表药为利血平，主要用于高血压病、因长期用药物偶致抑郁症，目前已很少用。
CAS号：
性质：又称抗肾上腺素能神经药、去甲肾上腺素能神经阻滞药。指一类通过影响递质去甲肾上腺素在去甲肾上腺素能神经末梢的贮存，产生拮抗去甲肾上腺素能神经作用的药物。与抗肾上腺素药比较，二者作用相似但作用部位不同，抗肾上腺素药作用于效应器细胞的受体，而肾上腺素神经阻滞药作用于去甲肾上腺素能神经末梢。代表药为利血平，主要用于高血压病、因长期用药物偶致抑郁症，目前已很少用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条